Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Oxford Nanopore Technologies Plc
(OP:
ONTTF
)
2.000
+0.030 (+1.52%)
Streaming Delayed Price
Updated: 3:18 PM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oxford Nanopore Technologies Plc
ONT releases Remora: Most Comprehensive Methylation
May 26, 2022
Oxford Nanopore integrates "Remora": a tool to enable real-time, high-accuracy epigenetic insights with nanopore sequencing software MinKNOW
From
Oxford Nanopore Technologies plc
Via
AccessWire
Oxford Nanopore Announces Tech Updates
May 20, 2022
Oxford Nanopore delivers technology update at annual London Calling conference: bringing together years of innovation to showcase one sensing platform for all biological analyses
From
Oxford Nanopore Technologies plc
Via
AccessWire
ONT Opens User Conference, Rich Science Programme
May 19, 2022
Oxford Nanopore's London Calling conference opens; amongst a breadth of ground-breaking research, increasing attention on human and cancer genomics
From
Oxford Nanopore Technologies plc
Via
AccessWire
ONT Chosen for Comprehensive Human Genome Program
May 13, 2022
Oxford Nanopore sequencing selected to generate comprehensive insights by characterising a more complete genome using samples from the 1000 Genomes Project Oxford Nanopore technology will enable the...
From
Oxford Nanopore Technologies plc
Via
AccessWire
Genomics England Expands Nanopore Use in Cancer
April 04, 2022
Genomics England expands use of Oxford Nanopore sequencing in cancer Oxford Nanopore technology will be used by Genomics England to investigate and validate at increasing scale the benefits of...
From
Oxford Nanopore Technologies plc
Via
AccessWire
ONT Shows New High-Accuracy, High-Output Chemistry
March 30, 2022
Oxford Nanopore technology update: CTO Clive G Brown unveils latest sequencing chemistry with highest performance to date, Short Fragment Mode and latest methylation performance evaluations Clive G...
From
Oxford Nanopore Technologies plc
Via
AccessWire
Oxford Nanopore Technologies PLC Announces Nanopore Sequencing Profiles TB: Find Evaluation
March 24, 2022
OXFORD, UK / ACCESSWIRE / March 24, 2022 / Oxford Nanopore announces positive evaluation of new method for rapid drug-resistant tuberculosis (DR-TB) profiling On World Tuberculosis Day, Oxford...
From
Oxford Nanopore Technologies plc
Via
AccessWire
Oxford Nanopore Releases Short Fragment Mode
March 23, 2022
Oxford Nanopore releases Short Fragment Mode: a new tool for real-time sequencing of short fragments of DNA Today, Short Fragment Mode will be integrated into the operating software that drives...
From
Oxford Nanopore Technologies plc
Via
AccessWire
Oxford Nanopore Technologies plc Announces Publication: Nanopore IDs >50 Genetic Diseases
March 08, 2022
Researchers Use Oxford Nanopore Technology To Develop a Single Test Method To Characterise More Than 50 Genetic Diseases In a Study Published in Science Advances, a Team From the Garvan Institute of...
From
Oxford Nanopore Technologies plc
Via
AccessWire
Fastest Human Genome Sequence Uses Oxford Nanopore
January 13, 2022
Scientists describe new approach in NEJM, using Oxford Nanopore DNA sequencing technology to improve prognosis in critically ill patients, in less than 8 hours Oxford Nanopore worked with a team led by...
From
Oxford Nanopore Technologies plc
Via
AccessWire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today